- €5.48bn
- €6.29bn
- €1.15bn
- 90
- 22
- 71
- 68
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 706 | 881 | 1,238 | 1,361 | 1,148 |
Cost of Revenue | |||||
Gross Profit | 489 | 603 | 825 | 901 | 741 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 488 | 557 | 818 | 1,010 | 932 |
Operating Profit | 218 | 324 | 419 | 351 | 216 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 216 | 321 | 399 | 326 | 201 |
Provision for Income Taxes | |||||
Net Income After Taxes | 176 | 248 | 311 | 240 | 159 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 176 | 248 | 311 | 241 | 160 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 176 | 248 | 311 | 241 | 160 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.27 | 4.58 | 5.7 | 4.62 | 3.17 |
Dividends per Share |